Information:
Error:
ID
12471
Description
The purpose of the study is to assess the efficacy (prevention of vascular events) and safety (especially bleedings) of Ticagrelor (AZD6140) compared with Clopidogrel, both given on top of low dose aspirin, in Asian/Japanese patients with acute coronary syndrome and a planned percutaneous coronary intervention (PCI). https://clinicaltrials.gov/ct2/show/NCT01294462
Link
https://clinicaltrials.gov/ct2/show/NCT01294462
Keywords
Versions (2)
- 7/28/15 7/28/15 -
- 11/21/15 11/21/15 -
Uploaded on
November 21, 2015
DOI
To request one please log in.
License
Creative Commons BY 4.0
Model comments :
You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.
Itemgroup comments for :
Item comments for :
In order to download data models you must be logged in. Please log in or register for free.
Eligibility Ticagrelor Versus Clopidogrel Acute Coronary Syndrome NCT01294462
Similar models
Eligibility criteria
- StudyEvent: ODM
Name
Type
Description | Question | Decode (Coded Value)
Data type
Alias
Informed consent
Item
Provision of signed informed consent
boolean
C0021430 (UMLS CUI-1)
STEMI
Item
Index event of ST segment elevation ACS
boolean
C1536220 (UMLS CUI-1)
NSTEMI
Item
Index event of non-ST segment elevation ACS
boolean
C3537184 (UMLS CUI-1)
PCI complication
Item
Index event is an acute complication of percutaneous coronary intervention
boolean
C0009566 (UMLS CUI [1,1])
C1532338 (UMLS CUI [1,2])
C1532338 (UMLS CUI [1,2])
PCI
Item
Patient has undergone Percutaneous Coronary Intervention (PCI) after the index event before the first dose of study treatment
boolean
C1532338 (UMLS CUI-1)
anticoagulation therapy
Item
Oral anticoagulation therapy that cannot be stopped
boolean
C0003281 (UMLS CUI-1)
Bradycardia
Item
The conditions associated with increased risk of bradycardiac events
boolean
C0428977 (UMLS CUI-1)